TGA Targets False Claims for Bioresonance Devices

Australia’s Therapeutic Goods Administration (TGA) said it’s cracking down on advertisements for bioresonance devices and similar technology that don’t comply with its regulations.

The agency flagged bioresonance — a non-invasive therapy that uses electrodes for diagnosis and treatment — for a high rate of non-compliance in advertising and noted that it has been the focus of previous regulatory action.

The agency noted a list of false treatment claims seen in ads, including that bioresonance can help or treat cancers, joint pain, osteoarthritis and disorders like chronic fatigue and insomnia, among others.